Status:
COMPLETED
Cognitive Impairment and Neuropsychiatric Manifestations of Neurobrucellosis
Lead Sponsor:
Mansoura University Hospital
Conditions:
Brucellosis
Eligibility:
All Genders
18+ years
Brief Summary
Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widel...
Detailed Description
Brucellosis is a common zoonotic infection in many parts of the world including the Mediterranean and Middle Eastern countries. Neurobrucellosis may develop at any stage of disease and may have widel...
Eligibility Criteria
Inclusion
- Patients \>18 years of age with laboratory-confirmed brucellosis
Exclusion
- Previous neuropsychiatric disease
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT04301752
Start Date
February 1 2019
End Date
March 1 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospital
Al Mansurah, Egypt